TYLENOL w. CODEINE #3 CIII
Generic Name and Formulations:
Codeine phosphate 30mg, acetaminophen 300mg; tabs; contains sulfites.
Janssen Pharmaceuticals, Inc.
Indications for TYLENOL w. CODEINE #3:
Mild to moderately severe pain.
#3: 1–2 tabs every 4 hours. #4: 1 tab every 4 hours.
Post-op pain management in children who have undergone tonsillectomy and/or adenoidectomy.
Risk of respiratory depression and death related to ultra-rapid metabolizers of codeine (esp. in children in post-op tonsillectomy and/or adenoidectomy). Hepatotoxicity (w. acetaminophen >4g/day). Obstructive sleep apnea. Head injury. Increased intracranial pressure. Acute abdomen. Impaired renal, hepatic, thyroid, or adrenocortical function. GI or GU obstruction. Addison's disease. Asthma. Drug abusers. Sulfite sensitivity. Elderly. Debilitated. Labor and delivery. Pregnancy (Cat.C). Nursing mothers.
Potentiation with alcohol, general anesthetics, tranquilizers (eg, chlordiazepoxide, sedative-hypnotics), other CNS depressants, MAOIs, tricyclic antidepressants, anticholinergics.
Opioid + analgesic.
Drowsiness, lightheadedness, dizziness, sedation, shortness of breath, nausea, vomiting, constipation, urinary retention, rash; overdosage: respiratory depression, hepatotoxicity.
#3—100, 1000; #4—100, 500
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|